Bicara Therapeutics BCAX Earnings Call Transcripts

NASDAQ BCAX
$10.18 +0.20 (+2.00%)
At close: Nov 10, 2026 · 4:00 PM EST
3 earnings calls on file for Bicara Therapeutics, from Q1 2026 to Q2 2026. Each transcript opens in a new tab.
Latest earnings call

Bicara Therapeutics Q2 2026 Earnings Call

Aug 11, 2026 5,910 words · 26 min read
  • Claire MazumdarChief Executive Officer
  • Ryan CohlheppPresident and Chief Operating Officer
  • Ivan HyepChief Financial Officer
  • Tanya GreenChief Development Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Bicara Therapeutics Earnings Call Transcripts

Calls3
LatestAug 11, 2026
SinceQ1 2026

Fiscal 2026

Fiscal 2025

All 3 Bicara Therapeutics transcripts Register to get access to Bicara Therapeutics’s earnings call transcripts.